Abstract
Current cancer treatments require improvements in selectivity and efficacy. Surgery, radiation, and chemotherapy approaches result in patient’s suffering over time due to the development of severe side-effects that simultaneously condition adherence to therapy. Biologically active peptides, in particular antimicrobial peptides (AMPs), are versatile molecules in terms of biological activities. The cytotoxic activities of several AMPs turn this group of molecules into an amazing pool of new templates for anticancer drug development. However, several unmet challenges limit application of peptides in cancer therapy. The mechanism(s) of action of the peptides need better description and understanding, and innovative targets have to be discovered and explored, facilitating drug design and development. In this chapter, we explore the natural occurring AMPs as potential new anticancer peptides (ACPs) for cancer prevention and treatment. Their modes of action, selectivity to tumor compared to normal cells, preferential targets, and applications, but also their weaknesses, are described and discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Benna S, Shai Y, Jacobsen F, Steinstraesser L (2011) Oncolytic activities of host defense peptides. Int J Mol Sci 12(11):8027–8051. doi:10.3390/ijms12118027
Albrethsen J, Bogebo R, Gammeltoft S, Olsen J, Winther B, Raskov H (2005) Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. BMC Cancer 5:8. doi:10.1186/1471-2407-5-8
Albrethsen J, Moller CH, Olsen J, Raskov H, Gammeltoft S (2006) Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer. Eur J Cancer 42(17):3057–3064. doi:10.1016/j.ejca.2006.05.039
Alves CS, Melo MN, Franquelim HG, Ferre R, Planas M, Feliu L, Bardaji E, Kowalczyk W, Andreu D, Santos NC, Fernandes MX, Castanho MARB (2010) Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR. J Biol Chem 285(36):27536–27544. doi:10.1074/jbc.M110.130955
Arouri A, Dathe M, Blume A (2009) Peptide induced demixing in PG/PE lipid mixtures: A mechanism for the specificity of antimicrobial peptides towards bacterial membranes? Biochimica Et Biophysica Acta-Biomembranes 1788(3):650–659. doi:10.1016/j.bbamem.2008.11.022
Barras D, Widmann C (2011) Promises of apoptosis-inducing peptides in cancer therapeutics. Curr Pharm Biotechnol 12(8):1153–1165
Bateman A, Singh A, Jothy S, Fraser R, Esch F, Solomon S (1992) The levels and biologic action of the human neutrophil granule peptide Hp-1 in lung-tumors. Peptides 13(1):133–139. doi:10.1016/0196-9781(92)90152-S
Bhutia SK, Maiti TK (2008) Targeting tumors with peptides from natural sources. Trends Biotechnol 26(4):210–217. doi:10.1016/j.tibtech.2008.01.002
Chan SC, Hui L, Chen HM (1998) Enhancement of the cytolytic effect of anti-bacterial cecropin by the microvilli of cancer cells. Anticancer Res 18(6A):4467–4474
Chaudhary J, Munshi M (1995) Scanning electron-microscopic analysis of breast aspirates. Cytopathology 6(3):162–167. doi:10.1111/j.1365-2303.1995.tb00469.x
Chen CX, Hu J, Zeng P, Pan F, Yaseen M, Xu H, Lu JR (2014) Molecular mechanisms of anticancer action and cell selectivity of short alpha-helical peptides. Biomaterials 35(5):1552–1561. doi:10.1016/j.biomaterials.2013.10.082
Conibear AC, Craik DJ (2014) The chemistry and biology of theta defensins. Angewandte Chemie-International Edition 53(40):10612–10623. doi:10.1002/anie.201402167
Craik DJ (2012) Host-defense activities of cyclotides. Toxins 4(2):139–156. doi:10.3390/toxins4020139
Craik DJ, Fairlie DP, Liras S, Price D (2013) The future of peptide-based drugs. Chem Biol Drug Des 81(1):136–147. doi:10.1111/cbdd.12055
de Azevedo RA, Figueiredo CR, Ferreira AK, Matsuo AL, Massaoka MH, Girola N, Auada AV, Farias CF, Pasqualoto KF, Rodrigues CP, Barbuto JA, Levy D, Bydlowski SP, de Sa-Junior PL, Travassos LR, Lebrun I (2015) Mastoparan induces apoptosis in B16F10-Nex2 melanoma cells via the intrinsic mitochondrial pathway and displays antitumor activity in vivo. Peptides 68:113–119. doi:10.1016/j.peptides.2014.09.024
Droin N, Hendra JB, Ducoroy P, Solary E (2009) Human defensins as cancer biomarkers and antitumour molecules. J Proteomics 72(6):918–927. doi:10.1016/j.jprot.2009.01.002
Eliassen LT, Berge G, Leknessund A, Wikman M, Lindin I, Lokke C, Ponthan F, Johnsen JI, Sveinbjornsson B, Kogner P, Flaegstad T, Rekdal O (2006) The antimicrobial peptide, Lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo. Int J Cancer 119(3):493–500. doi:10.1002/ijc.21886
Evans J, Wang YD, Shaw KP, Vernon LP (1989) Cellular-responses to pyrularia thionin are mediated by Ca-2+ influx and phospholipase-A2 activation and are inhibited by thionin tyrosine iodination. Proc Natl Acad Sci USA 86(15):5849–5853. doi:10.1073/pnas.86.15.5849
Fang XY, Chen W, Fan JT, Song R, Wang L, Gu YH, Zeng GZ, Shen Y, Wu XF, Tan NH, Xu Q, Sun Y (2013) Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1-AKT interaction. Toxicol Appl Pharmacol 267(1):95–103. doi:10.1016/j.taap.2012.12.010
Fernebro J (2011) Fighting bacterial infections-future treatment options. Drug Resist Updates 14(2):125–139. doi:10.1016/j.drup.2011.02.001
Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20(1):122–128
Freire JM, Gaspar D, Veiga AS, Castanho MARB (2015) Shifting gear in antimicrobial and anticancer peptides biophysical studies: from vesicles to cells. J Pept Sci 21(3):178–185. doi:10.1002/psc.2741
Furlong SJ, Ridgway ND, Hoskin DW (2008) Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin. Int J Oncol 32(3):537–544
Galvez AF, Chen N, Macasieb J, de Lumen BO (2001) Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res 61(20):7473–7478
Ganz T, Lehrer RI (1998) Antimicrobial peptides of vertebrates. Curr Opin Immunol 10(1):41–44. doi:10.1016/S0952-7915(98)80029-0
Gaspar D, Veiga AS, Sinthuvanich C, Schneider JP, Castanho MARB (2012) Anticancer peptide SVS-1: efficacy precedes membrane neutralization. Biochemistry 51(32):6263–6265. doi:10.1021/bi300836r
Gaspar D, Veiga AS, Castanho MA (2013) From antimicrobial to anticancer peptides. A review. Front Microbiol 4:294. doi:10.3389/fmicb.2013.00294
Gaspar D, Freire JM, Pacheco TR, Barata JT, Castanho MARB (2015) Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics. Biochimica Et Biophysica Acta-Molecular Cell Res 1853(2):308–316. doi:10.1016/j.bbamcr.2014.11.006
Gera JF, Lichtenstein A (1991) Human neutrophil peptide defensins induce single-strand DNA breaks in target-cells. Cell Immunol 138(1):108–120. doi:10.1016/0008-8749(91)90136-Y
Guzman-Rodriguez JJ, Ochoa-Zarzosa A, Lopez-Gomez R, Lopez-Meza JE (2015) Plant antimicrobial peptides as potential anticancer agents. Biomed Res Int. doi:10.1155/2015/735087
Harris F, Dennison SR, Singh J, Phoenix DA (2013) On the selectivity and efficacy of defense peptides with respect to cancer cells. Med Res Rev 33(1):190–234. doi:10.1002/med.20252
He WJ, Chan LY, Zeng GZ, Daly NL, Craik DJ, Tan NH (2011) Isolation and characterization of cytotoxic cyclotides from Viola philippica. Peptides 32(8):1719–1723. doi:10.1016/j.peptides.2011.06.016
Henriques ST, Huang YH, Castanho MARB, Bagatolli LA, Sonza S, Tachedjian G, Daly NL, Craik DJ (2012) Phosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions. J Biol Chem 287(40):33629–33643. doi:10.1074/jbc.M112.372011
Hernandez-Ledesma B, Hsieh CC, de Lumen BO (2009) Lunasin, a novel seed peptide for cancer prevention. Peptides 30(2):426–430. doi:10.1016/j.peptides.2008.11.002
Holterman DA, Diaz JI, Blackmore PF, Davis JW, Schellhammer PF, Corica A, Semmes OJ, Vlahou A (2006) Overexpression of alpha-defensin is associated with bladder cancer invasiveness. Urol Oncol-Semin Original Inv 24(2):97–108. doi:10.1016/j.urolonc.2005.07.010
Hoskin DW, Ramamoorthy A (2008) Studies on anticancer activities of antimicrobial peptides. Biochimica Et Biophysica Acta-Biomembranes 1778(2):357–375. doi:10.1016/j.bbamem.2007.11.008
Hsieh EA, Chai CM, de Lumen BO, Neese RA, Hellerstein MK (2004) Dynamics of keratinocytes in vivo using (H2O)-H-2 labeling: a sensitive marker of epidermal proliferation state. J Inv Dermatol 123(3):530–536. doi:10.1111/j.0022-202X.2004.23303.x
Huang W, Seo J, Willingham SB, Czyzewski AM, Gonzalgo ML, Weissman IL, Barron AE (2014) Learning from host-defense peptides: cationic, amphipathic peptoids with potent anticancer activity. Plos One 9(2). doi:10.1371/journal.pone.0090397
Hughes P, Dennis E, Whitecross M, Llewellyn D, Gage P (2000) The cytotoxic plant protein, beta-purothionin, forms ion channels in lipid membranes. J Biol Chem 275(2):823–827. doi:10.1074/jbc.275.2.823
Iwasaki T, Ishibashi J, Tanaka H, Sato M, Asaoka A, Taylor D, Yamakawa M (2009) Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface. Peptides 30(4):660–668. doi:10.1016/j.peptides.2008.12.019
Jenssen H, Andersen JH, Uhlin-Hansen L, Gutteberg TJ, Rekdal O (2004) Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antiviral Res 61(2):101–109. doi:10.1016/j.antiviral.2003.09.001
Kohno M, Horibe T, Haramoto M, Yano Y, Ohara K, Nakajima O, Matsuzaki K, Kawakami K (2011) A novel hybrid peptide targeting EGFR-expressing cancers. Eur J Cancer 47(5):773–783. doi:10.1016/j.ejca.2010.10.021
Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkila P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E, Pasqualini R (1999) Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 17(8):768–774. doi:10.1038/11703
Kuriyama I, Miyazaki A, Tsuda Y, Yoshida H, Mizushina Y (2013) Inhibitory effect of novel somatostatin peptide analogues on human cancer cell growth based on the selective inhibition of DNA polymerase beta. Bioorg Med Chem 21(2):403–411. doi:10.1016/j.bmc.2012.11.024
Lacerda AF, Vasconcelos EA, Pelegrini PB, Grossi de Sa MF (2014) Antifungal defensins and their role in plant defense. Front Microbiol 5:116. doi:10.3389/fmicb.2014.00116
Leung HW, Wang Z, Yue GGL, Zhao SM, Lee JKM, Fung KP, Leung PC, Lau CBS, Tan NH (2015) Cyclopeptide RA-V inhibits cell adhesion and invasion in both estrogen receptor positive and negative breast cancer cells via PI3 K/AKT and NF-kappa B signaling pathways. Biochimica Et Biophys Acta-Mol Cell Res 1853(8):1827–1840. doi:10.1016/j.bbamcr.2015.04.020
Loeza-Angeles H, Sagrero-Cisneros E, Lara-Zarate L, Villagomez-Gomez E, Lopez-Meza JE, Ochoa-Zarzosa A (2008) Thionin Thi2.1 from Arabidopsis thaliana expressed in endothelial cells shows antibacterial, antifungal and cytotoxic activity. Biotechnol Lett 30(10):1713–1719. doi:10.1007/s10529-008-9756-8
Mader JS, Salsman J, Conrad DM, Hoskin DW (2005) Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol Cancer Ther 4(4):612–624. doi:10.1158/1535-7163.Mct-04-0077
Mai JC, Mi ZB, Kim SH, Ng B, Robbins PD (2001) A proapoptotic peptide for the treatment of solid tumors. Cancer Res 61(21):7709–7712
Medina SH, Schneider JP (2015) Cancer cell surface induced peptide folding allows intracellular translocation of drug. J Controlled Release 209:317–326. doi:10.1016/j.jconrel.2015.05.267
Mello EO, Ribeiro SFF, Carvalho AO, Santos IS, Da Cunha M, Santa-Catarina C, Gomes VM (2011) Antifungal activity of PvD1 defensin involves plasma membrane permeabilization, inhibition of medium acidification, and induction of ROS in fungi cells. Curr Microbiol 62(4):1209–1217. doi:10.1007/s00284-010-9847-3
Mohri Y, Mohri T, Wei W, Qi YJ, Martin A, Miki C, Kusunoki M, Ward DG, Johnson PJ (2009) Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer. Br J Cancer 101(2):295–302. doi:10.1038/sj.bjc.6605138
Mulder KCL, Lima LA, Miranda VJ, Dias SC, Franco OL (2013) Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides. Frontiers Microbiol 4. doi:10.3389/Fmicb.2013.00321
Muller CA, Markovic-Lipkovski J, Klatt T, Gamper J, Schwarz G, Beck H, Deeg M, Kalbacher H, Widmann S, Wessels JT, Becker V, Muller GA, Flad T (2002) Human alpha-defensins HNPs-1, -2, and -3 in renal cell carcinoma: influences on tumor cell proliferation. Am J Pathol 160(4):1311–1324. doi:10.1016/S0002-9440(10)62558-8
Ngai PHK, Ng TB (2005) Phaseococcin, an antifungal protein with antiproliferative and anti-HIV-1 reverse transcriptase activities from small scarlet runner beans. Biochem Cell Biol-Biochimie Et Biologie Cellulaire 83(2):212–220. doi:10.1139/O05-037
Ortiz-Martinez M, Winkler R, Garcia-Lara S (2014) Preventive and therapeutic potential of peptides from cereals against cancer. J Proteomics 111:165–183. doi:10.1016/j.jprot.2014.03.044
Ouellette AJ, Bevins CL (2001) Paneth cell defensins and innate immunity of the small bowel. Inflamm Bowel Dis 7(1):43–50. doi:10.1097/00054725-200102000-00007
Papo N, Shai Y (2005) Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 62(7–8):784–790. doi:10.1007/s00018-005-4560-2
Paredes-Gamero EJ, Casaes-Rodrigues RL, Moura GE, Domingues TM, Buri MV, Ferreira VH, Trindade ES, Moreno-Ortega AJ, Cano-Abad MF, Nader HB, Ferreira AT, Miranda A, Justo GZ, Tersariol IL (2012) Cell-permeable gomesin peptide promotes cell death by intracellular Ca(2+) overload. Mol Pharm 9(9):2686–2697. doi:10.1021/mp300251j
Poon IKH, Baxter AA, Lay FT, Mills GD, Adda CG, Payne JAE, Phan TK, Ryan GF, White JA, Veneer PK, van der Weerden NL, Anderson MA, Kvansakul M, Hulett MD (2014) Phosphoinositide-mediated oligomerization of a defensin induces cell lysis. Elife 3. doi:10.7554/eLife.01808
Reddy KVR, Yedery RD, Aranha C (2004) Antimicrobial peptides: premises and promises. Int J Antimicrob Agents 24(6):536–547. doi:10.1016/j.ijantimicag.2004.09.005
Riedl S, Zweytick D, Lohner K (2011) Membrane-active host defense peptides—challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 164(8):766–781. doi:10.1016/j.chemphyslip.2011.09.004
Rodrigues EG, Dobroff ASS, Cavarsan CF, Paschoalin T, Nimrichter L, Mortara RA, Santos EL, Fazio MA, Miranda A, Daffre S, Travassos LR (2008) Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin. Neoplasia 10(1):61–68. doi:10.1593/neo.07885
Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS (2011) Anti-angiogenic peptides for cancer therapeutics. Curr Pharm Biotechnol 12(8):1101–1116
Saar K, Lindgren M, Hansen M, Eiriksdottir E, Jiang Y, Rosenthal-Aizman K, Sassian M, Langel U (2005) Cell-penetrating peptides: a comparative membrane toxicity study. Anal Biochem 345(1):55–65. doi:10.1016/j.ab.2005.07.033
Sah BNP, Vasiljevic T, McKechnie S, Donkor ON (2015) Identification of anticancer peptides from bovine milk proteins and their potential roles in management of cancer: a critical review. Comprehensive Rev. Food Sci. Food Safety 14(2):123–138. doi:10.1111/1541-4337.12126
Salas CE, Badillo-Corona JA, Ramirez-Sotelo G, Oliver-Salvador C (2015) Biologically active and antimicrobial peptides from plants. Biomed Res Int. doi:10.1155/2015/102129
Schroder-Borm H, Bakalova R, Andra J (2005) The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine. FEBS Lett 579(27):6128–6134. doi:10.1016/j.febslet.2005.09.084
Schweizer F (2009) Cationic amphiphilic peptides with cancer-selective toxicity. Eur J Pharmacol 625(1–3):190–194. doi:10.1016/j.ejphar.2009.08.043
Seo MD, Won HS, Kim JH, Mishig-Ochir T, Lee BJ (2012) Antimicrobial peptides for therapeutic applications: a review. Molecules 17(10):12276–12286. doi:10.3390/molecules171012276
Sharma SV (1992) Melittin resistance - a counterselection for ras transformation. Oncogene 7(2):193–201
Silva ON, Porto WF, Migliolo L, Mandal SM, Gomes DG, Holanda HHS, Silva RSP, Dias SC, Costa MP, Costa CR, Silva MR, Rezende TMB, Franco OL (2012) Cn-AMP1: a new promiscuous peptide with potential for microbial infections treatment. Biopolymers 98(4):322–331. doi:10.1002/bip.22071
Sinthuvanich C, Veiga AS, Gupta K, Gaspar D, Blumenthal R, Schneider JP (2012) Anticancer beta-hairpin peptides: membrane-induced folding triggers activity. J Am Chem Soc 134(14):6210–6217. doi:10.1021/ja210569f
Stec B (2006) Plant thionins—the structural perspective. Cell Mol Life Sci 63(12):1370–1385. doi:10.1007/s00018-005-5574-5
Svangard E, Burman R, Gunasekera S, Lovborg H, Gullbo J, Goransson U (2007) Mechanism of action of cytotoxic cyclotides: cycloviolacin O2 disrupts lipid membranes. J Nat Prod 70(4):643–647. doi:10.1021/np070007v
Tanaka T (1997) Chemoprevention of human cancer: biology and therapy. Crit Rev Oncol Hematol 25(3):139–174. doi:10.1016/S1040-8428(97)00232-1
Tanaka T (2009) Colorectal carcinogenesis: review of human and experimental animal studies. J Carcinog 8:5
Torcato IM, Huang YH, Franquelim HG, Gaspar D, Craik DJ, Castanho MARB, Henriques ST (2013a) Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria. Biochimica Et Biophysica Acta-Biomembr 1828(3):944–955. doi:10.1016/j.bbamem.2012.12.002
Torcato IM, Huang YH, Franquelim HG, Gaspar DD, Craik DJ, Castanho MARB, Henriques ST (2013b) The antimicrobial activity of Sub3 is dependent on membrane binding and cell-penetrating ability. ChemBioChem 14(15):2013–2022. doi:10.1002/cbic.201300274
Vesely BA, Eichelbaum EJ, Alli AA, Sun Y, Gower WR, Vesely DL (2006) Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers. Eur J Clin Invest 36(11):810–819. doi:10.1111/j.1365-2362.2006.01721.x
Walensky LD, Kung AL, Escher I, Malia TJ, Barbuto S, Wright RD, Wagner G, Verdine GL, Korsmeyer SJ (2004) Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305(5689):1466–1470. doi:10.1126/science.1099191
Wang KR, Yan JX, Zhang BZ, Song JJ, Jia PF, Wang R (2009a) Novel mode of action of polybia-MPI, a novel antimicrobial peptide, in multi-drug resistant leukemic cells. Cancer Lett 278(1):65–72. doi:10.1016/j.canlet.2008.12.027
Wang YS, Li D, Shi HS, Wen YJ, Yang L, Xu N, Chen XC, Chen X, Chen P, Li J, Deng HX, Wang CT, Xie G, Huang S, Mao YQ, Chen LJ, Zhao X, Wei YQ (2009b) Intratumoral expression of mature human neutrophil peptide-1 mediates antitumor immunity in mice. Clin Cancer Res 15(22):6901–6911. doi:10.1158/1078-0432.CCR-09-0484
Wang YS, Li D, Shi HS, Wen YJ, Yang L, Xu N, Chen XC, Chen X, Chen P, Li J, Deng HX, Wang CT, Xie G, Huang S, Mao YQ, Chen LJ, Zhao X, Wei YQ (2009c) Intratumoral expression of mature human neutrophil peptide-1 mediates antitumor immunity in mice. Clin Cancer Res 15(22):6901–6911. doi:10.1158/1078-0432.CCR-09-0484
Wong JH, Ng TB (2005a) Lunatusin, a trypsin-stable antimicrobial peptide from lima beans (Phaseolus lunatus L.). Peptides 26 (11):2086–2092. doi:10.1016/j.peptides.2005.03.004
Wong JH, Ng TB (2005b) Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase. Peptides 26(7):1120–1126. doi:10.1016/j.peptides.2005.01.003
Wu DD, Gao YF, Qi YM, Chen LX, Ma YF, Li YZ (2014) Peptide-based cancer therapy: opportunity and challenge. Cancer Lett 351(1):13–22. doi:10.1016/j.canlet.2014.05.002
Yamada Y, Shinohara Y, Kakudo T, Chaki S, Futaki S, Kamiya H, Harashima H (2005) Mitochondrial delivery of mastoparan with transferrin liposornes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy. Int J Pharm 303(1–2):1–7. doi:10.1016/j.ijpharm.2005.06.009
Yang WH, Luo DF, Wang SX, Wang R, Chen R, Liu Y, Zhu T, Ma XY, Liu RH, Xu G, Meng L, Lu YP, Zhou JF, Ma D (2008) TMTP1, a novel tumor-homing peptide specifically targeting metastasis. Clin Cancer Res 14(17):5494–5502. doi:10.1158/1078-0432.CCR-08-0233
Yi ZF, Cho SG, Zhao H, Wu YY, Luo J, Li DL, Yi T, Xu X, Wu ZR, Liu M (2009) A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells. Int J Cancer 124(4):843–852. doi:10.1002/ijc.24027
Zhao BX, Zhao Y, Huang Y, Luo LM, Song P, Wang X, Chen S, Yu KF, Zhang X, Zhang Q (2012) The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel. Biomaterials 33(8):2508–2520. doi:10.1016/j.biomaterials.2011.11.078
Zheng LH, Wang YJ, Sheng J, Wang F, Zheng Y, Lin XK, Sun M (2011) Antitumor peptides from marine organisms. Marine Drugs 9(10):1840–1859. doi:10.3390/md9101840
Acknowledgments
FundaĂ§Ă£o para a CiĂªncia e a Tecnologia—MinistĂ©rio da EducaĂ§Ă£o e CiĂªncia (FCT-MEC, Portugal) is acknowledged for funding through SFRH/BPD/73500/2010 fellowship to Diana Gaspar and project grant PTDC/BBB-BQB/1693/2014.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gaspar, D., Castanho, M.A. (2016). Anticancer Peptides: Prospective Innovation in Cancer Therapy. In: Epand, R. (eds) Host Defense Peptides and Their Potential as Therapeutic Agents. Springer, Cham. https://doi.org/10.1007/978-3-319-32949-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-32949-9_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32947-5
Online ISBN: 978-3-319-32949-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)